An analysis of the incidence and survival rates of bone sarcoma patients in thailand: reports from population-based cancer registries 2001-2015.


Journal

Cancer epidemiology
ISSN: 1877-783X
Titre abrégé: Cancer Epidemiol
Pays: Netherlands
ID NLM: 101508793

Informations de publication

Date de publication:
02 2022
Historique:
received: 11 06 2021
revised: 28 10 2021
accepted: 30 10 2021
pubmed: 20 11 2021
medline: 16 4 2022
entrez: 19 11 2021
Statut: ppublish

Résumé

Epidemiology data from population-based cancer registries (PBCR) can be very valuable in the development of health policy and for improving the quality of cancer control strategies. This study analyzed the incidence of bone sarcomas in Thailand during 2001 - 2015 by analyzing data obtained from 5 PBCRs across country. Incidence rates per million person-years by sex, histological subtype, primary site and 5-year age group were calculated. Age-standardized incidence rates (ASR) were adjusted using the WHO's World Standard Population and comparisons between populations were done using standardized rate ratios (SRR). Incidence trends were evaluated using Joinpoint Trend Analysis. Survival rates were analyzed using STATA. The ASR of bone sarcomas in Thailand was 5.1/10 The lower overall survival rate of bone sarcoma represented the gap of bone sarcoma control program in Thailand. That indicates the need for improvement in health promotion, treatment process and chemotherapy for bone sarcoma patients in the future.

Sections du résumé

BACKGROUND
Epidemiology data from population-based cancer registries (PBCR) can be very valuable in the development of health policy and for improving the quality of cancer control strategies.
METHODS
This study analyzed the incidence of bone sarcomas in Thailand during 2001 - 2015 by analyzing data obtained from 5 PBCRs across country. Incidence rates per million person-years by sex, histological subtype, primary site and 5-year age group were calculated. Age-standardized incidence rates (ASR) were adjusted using the WHO's World Standard Population and comparisons between populations were done using standardized rate ratios (SRR). Incidence trends were evaluated using Joinpoint Trend Analysis. Survival rates were analyzed using STATA.
RESULTS
The ASR of bone sarcomas in Thailand was 5.1/10
CONCLUSION
The lower overall survival rate of bone sarcoma represented the gap of bone sarcoma control program in Thailand. That indicates the need for improvement in health promotion, treatment process and chemotherapy for bone sarcoma patients in the future.

Identifiants

pubmed: 34798388
pii: S1877-7821(21)00173-9
doi: 10.1016/j.canep.2021.102056
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

102056

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Jeerawan Klangjorhor (J)

Musculoskeletal Science and Translational Research Center, Department of Orthopedics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Donsuk Pongnikorn (D)

Cancer Registry Unit, Lampang Cancer Hospital, Lampang, Thailand.

Areerak Phanphaisarn (A)

Musculoskeletal Science and Translational Research Center, Department of Orthopedics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Parunya Chaiyawat (P)

Musculoskeletal Science and Translational Research Center, Department of Orthopedics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Pimpisa Teeyakasem (P)

Musculoskeletal Science and Translational Research Center, Department of Orthopedics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Pathacha Suksakit (P)

Center of Multidisciplinary Technology for Advanced Medicine (CMUTEAM), Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Arnat Pasena (A)

Center of Multidisciplinary Technology for Advanced Medicine (CMUTEAM), Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Sasimol Udomruk (S)

Musculoskeletal Science and Translational Research Center, Department of Orthopedics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Santhasiri Orrapin (S)

Center of Multidisciplinary Technology for Advanced Medicine (CMUTEAM), Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Samatit Pornwattanavate (S)

Musculoskeletal Science and Translational Research Center, Department of Orthopedics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Narate Waisri (N)

Chiang Mai Cancer Registry, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.

Karnchana Daoprasert (K)

Cancer Registry Unit, Lampang Cancer Hospital, Lampang, Thailand.

Taweechok Wisanuyotin (T)

Department of Orthopaedic, Faculty of Medicine, Khon Kaen University, Khon Kean, Thailand.

Chalongpon Santong (C)

Cancer Unit, Srinagarind Hospital, Faculty of Medicine, Khon Kaen University, Khon Kean, Thailand.

Suleeporn Sangrajrang (S)

Health System Development, National Cancer Institute, Bangkok, Thailand.

Siriphon Sitthikong (S)

Cancer Registry Unit, National Cancer Institute, Bangkok, Thailand.

Pakjai Tuntarattanapong (P)

Department of Orthopaedic, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.

Paradee Prechawittayakul (P)

Cancer Information Center, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand.

Dumnoensun Pruksakorn (D)

Musculoskeletal Science and Translational Research Center, Department of Orthopedics, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Center of Multidisciplinary Technology for Advanced Medicine (CMUTEAM), Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand. Electronic address: dumnoensun.p@cmu.ac.th.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH